Opportunity overview
This modification effects an extension of the Framework Agreement duration from 30 June 2024 until 31 March 2025. The modification notice is advised at Framework Agreement level only and so it does not detail individual Lots. All Terms and Conditions for the Framework Agreement remain in place.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Roche Products Ltd
- Contract value
- £13.8m
- Awarded
- Not supplied
- Contract signed
- 27 May 2020
- Award ID
- 012236-2025-NP93420-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Roche Products Ltd
- Contract value
- £15.7m
- Awarded
- Not supplied
- Contract signed
- 27 May 2020
- Award ID
- 016918-2024-NP93420-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
Lots
- This contract modification, effecting an extension of the Framework Agreement duration from 1 April 2025 until 31 March 2026, has been agreed between the supplier and the Authority on behalf of NHS Scotland to meet the additional demands of the Scottish Health and Social Care sector. This modification has been approved to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.Value not stated